当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析 - 现金流量表

泓博医药

(301230)

  

流通市值:63.24亿  总市值:70.31亿
流通股本:1.63亿   总股本:1.81亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金316,131,629.31154,412,808.38554,924,593.35417,894,006.74
  收到的税费返还1,718,091.97409,896.583,489,204.544,963,589.87
  收到其他与经营活动有关的现金28,276,182.5221,709,640.546,457,583.5328,857,588.78
  经营活动现金流入小计346,125,903.8176,532,345.46604,871,381.42451,715,185.39
  购买商品、接受劳务支付的现金93,083,374.9842,920,916.56172,243,284.85130,668,143.95
  支付给职工以及为职工支付的现金145,009,068.8375,662,585.84251,268,300.46179,647,631.85
  支付的各项税费7,000,073.662,704,255.0212,495,888.2111,799,948.15
  支付其他与经营活动有关的现金29,018,576.9625,497,112.6833,351,965.7747,085,149.03
  经营活动现金流出小计274,111,094.43146,784,870.1469,359,439.29369,200,872.98
  经营活动产生的现金流量净额72,014,809.3729,747,475.36135,511,942.1382,514,312.41
二、投资活动产生的现金流量:
  收回投资收到的现金245,857,843.34160,818,302.3923,000,00020,000,000
  取得投资收益收到的现金11,715,583.616,807,055.73105,380.53105,380.53
  处置固定资产、无形资产和其他长期资产收回的现金净额270270121,442-
  投资活动现金流入小计257,573,696.95167,625,628.1223,226,822.5320,105,380.53
  购建固定资产、无形资产和其他长期资产支付的现金39,625,629.6117,318,035.7843,316,262.0130,394,584.71
  投资支付的现金222,800,000154,800,00023,300,00023,300,000
  投资活动现金流出小计262,425,629.61172,118,035.7866,616,262.0153,694,584.71
  投资活动产生的现金流量净额-4,851,932.66-4,492,407.66-43,389,439.48-33,589,204.18
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,649,800---
  取得借款收到的现金5,750,000-25,664,755.5825,664,755.58
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计9,399,800-25,664,755.5825,664,755.58
  偿还债务支付的现金10,000,000-25,664,755.5817,653,171.34
  分配股利、利润或偿付利息支付的现金15,219,312.812,287,869.1854,044,722.9845,726,520.92
  支付其他与筹资活动有关的现金14,709,413.967,520,375.3525,823,977.618,303,602.25
  筹资活动现金流出小计39,928,726.7619,808,244.53105,533,456.1681,683,294.51
  筹资活动产生的现金流量净额-30,528,926.76-19,808,244.53-79,868,700.58-56,018,538.93
四、汇率变动对现金及现金等价物的影响-2,973,470.67-1,553,587.611,815,915.652,251,028.46
五、现金及现金等价物净增加额33,660,479.283,893,235.5614,069,717.72-4,842,402.24
  加:期初现金及现金等价物余额52,818,664.8952,818,664.8938,748,947.1738,748,947.17
  期末现金及现金等价物余额86,479,144.1756,711,900.4552,818,664.8933,906,544.93
补充资料:
  净利润28,729,363.74-34,294,767.32-
  资产减值准备10,255,861.78-16,017,088.85-
  固定资产和投资性房地产折旧14,898,912.31-28,073,318.34-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,898,912.31-28,073,318.34-
  无形资产摊销282,148.7-502,802.06-
  长期待摊费用摊销22,151,892.38-42,971,430.92-
  处置固定资产、无形资产和其他长期资产的损失---41,517.55-
  固定资产报废损失129,563.43-301,281.49-
  公允价值变动损失-8,792,384.73--6,996,140.63-
  财务费用6,675,658.58-6,359,371.37-
  投资损失-11,631,711.8--105,380.53-
  递延所得税-2,495,746.3--15,539,703.94-
  其中:递延所得税资产减少-3,620,694.56--16,388,888.96-
    递延所得税负债增加1,124,948.26-849,185.02-
  存货的减少-11,546,029.6--16,890,222.3-
  经营性应收项目的减少11,233,942.39--16,791,347.52-
  经营性应付项目的增加-2,481,678.04-34,331,004.08-
  其他3,430,284.04-6,116,980.22-
  现金的期末余额86,479,144.17-52,818,664.89-
  减:现金的期初余额52,818,664.89-38,748,947.17-
  现金及现金等价物的净增加额33,660,479.28-14,069,717.72-
公告日期2026-08-282026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑